Abstract Body

Background

Pathogenic retroviral infection, such as HIV/simian immunodeficiency virus (SIV), causes T cell lymphopenia. A fraction of people living with HIV, known as immunological nonresponders (INRs), present highly reduced thymic output despite complete viral suppression under therapy. The thymus, responsible for T cell regeneration, lacks autonomy in its ability to self-renew T cell committed progenitors, thereby relying on a continuous supply of thymus-seeding progenitors (TSPs) from the bone marrow (BM). BM Hematopoietic stem and progenitor cells (HSPCs) are known to exhibit a myeloid lineage bias under pathogenic inflammation. However, their T cell lineage bias is unknown. 

Methods

Here, we tracked T cell lineage bias of BM-derived HSPCs longitudinally upon pathogenic retroviral infection. We utilized the SIV/Rhesus macaque (RM) model of HIV/AIDS, combined with Rhesus and human-thymus independent artificial organoids (RhATO/hATO). The HSPCs derived at day 0 (pre-infection) and at weeks 2, 4, 12, and 16 post-infection were differentiated in RhATO. The potential impact on the magnitude and stage of T-cell-committed differentiation of HSPCs was analyzed. Further, the RhATO and hATO were modelled to recapitulate thymopoiesis under the influence of viral and host factors, and the thymic potential of BM-derived HSPCs was analyzed.

Results

We report a rapid decline in CD4–CD8– double negative CD34+CD7+ TSP population in BM upon SIV infection of RMs. Consistently, BM-derived HSPCs from SIV-infected RMs showed significantly reduced ability to differentiate into thymocytes as early as week 2 post-infection. The decline in thymic potential was independent of HSPCs abundance in BM, their lymphoid priming, or multipotent state. Plasma interleukin (IL)-6 strongly correlated with the decline in HSPCs’ thymic potential. Bulk RNASeq and proteomics of BM HSPCs showed an elevated inflammatory response and reduced T cell developmental program. Ex vivo treatment of SIV/HIV naïve RM and human HSPCs with IL-6 rapidly inhibited their T cell specification, and IL-6-receptor blockade reversed HSPCs thymic potential in the presence of IL-6.

Conclusions

We report that inflammation, and particularly IL-6, inhibits T cell lineage bias of BM HSPCs during retroviral infection. Such a mechanism may account for disparities in T cell reconstitution observed in people living with HIV following treatment with ART, and has implications for promoting T cell regeneration in INRs.